Combination therapy with 6-mercaptopurine (NSC-755) and allopurinol (NSC-1390) during induction and maintenance of remission of acute leukemia in children. 1969

A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000493 Allopurinol A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. Allohexal,Allohexan,Alloprin,Allopurin,Allorin,Allpargin,Allural,Apulonga,Apurin,Atisuril,Bleminol,Caplenal,Capurate,Cellidrin,Embarin,Foligan,Hamarin,Jenapurinol,Lopurin,Lysuron,Milurit,Milurite,Novopurol,Pan Quimica,Progout,Pureduct,Purinol,Remid,Rimapurinol,Roucol,Suspendol,Tipuric,Uribenz,Uridocid,Uripurinol,Urosin,Urtias,Xanthomax,Xanturic,Zygout,Zyloprim,Zyloric
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H

Related Publications

A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
April 1965, Cancer chemotherapy reports,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
June 1967, Cancer chemotherapy reports,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
February 1968, Cancer chemotherapy reports,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
August 1972, Cancer chemotherapy reports,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
June 1972, Cancer research,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
March 1964, Cancer chemotherapy reports,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
January 1989, Medical oncology and tumor pharmacotherapy,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
January 1988, Medical oncology and tumor pharmacotherapy,
A S Levine, and H L Sharp, and J Mitchell, and W Krivit, and M E Nesbit
March 2016, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!